北美原发性闭角型青光眼市场 – 行业趋势和 2028 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical North America Primary Angle Closure Glaucoma Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美原发性闭角型青光眼市场 – 行业趋势和 2028 年预测

  • Pharmaceutical
  • Published Report
  • Aug 2021
  • North America
  • 350 页面
  • 桌子數： 35
  • 图号： 36
立即购买 立即购买

North America Primary Angle Closure Glaucoma Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2021 –2028
Diagram Market Size (Base Year)
 USD 113.24 Million
Diagram Market Size (Forecast Year)
 USD 176.34 Million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>北美原发性闭角型青光眼市场，按疾病类型（急性闭角型青光眼和慢性闭角型青光眼）、类型（诊断和治疗）、最终用户（医院、门诊手术中心、专科诊所等）、分销渠道（直接招标、零售销售等）、国家（美国、加拿大、墨西哥）划分的行业趋势及预测至 2028 年。

北美原发性闭角型青光眼市场

市场分析与洞察：北美原发性闭角型青光眼市场

北美原发性闭角型青光眼市场预计将在 2021 年至 2028 年的预测期内实现显着增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 5.7%，预计将从 2020 年的 1.1324 亿美元达到 2028 年的 1.7634 亿美元。闭角型青光眼患病率的上升和老年人口的增加是推动预测期内市场增长的主要驱动因素。

青光眼是一组损害视神经的眼部疾病，视神经的正常功能是良好视力的必要条件。这种损害通常是由于眼压异常高造成的。原发性房角闭合 (PAC) 是指前房角的闭合，在没有青光眼性视神经病变的情况下，这会导致房水流出受阻和眼压升高。PAC 通常是双侧的；原发性房角闭合性青光眼市场包括早期检测原发性房角闭合性青光眼的技术，以便进行未来的手术治疗方法，从而降低与原发性房角闭合相关的失明率。该病在早期无症状，导致对原发性房角闭合性青光眼的诊断不当或不准确，从而导致错误治疗，给患者带来额外负担，并导致诊断产品的可靠性降低。

闭角型青光眼患病率的上升和老年人口的增加正在推动北美原发性闭角型青光眼市场的增长。然而，PACG 的高手术成本和报销不足预计将阻碍预测期内的市场增长。另一方面，最近管理机构的批准和政府针对青光眼的举措的增加预计将推动市场增长。缺乏熟练的专业人员和有限的治疗机会可能会对市场增长构成挑战，

北美原发性闭角型青光眼市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预​​期目标。   

北美原发性闭角型青光眼市场

北美原发性闭角型青光眼市场范围和市场规模

北美原发性闭角型青光眼市场根据疾病类型、类型、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

  • 根据疾病类型，原发性闭角型青光眼市场分为急性闭角型青光眼和慢性闭角型青光眼。2021 年，由于急性病例发病率高，急性闭角型青光眼细分市场预计将在原发性闭角型青光眼市场中占据主导地位。闭角型青光眼急性发作风险高，眼科医生诊断的病例数最多为急性闭角型青光眼。
  • 根据类型，原发性闭角型青光眼市场分为诊断和治疗。2021 年，诊断部分预计将在原发性闭角型青光眼市场中占据主导地位，因为诊断有初级检测和次级检测选项，医生在正确诊断后只会选择医疗程序。该市场的治疗部分完全基于手术干预，因此治疗的市场份额低于诊断。
  • 根据最终用户，原发性闭角型青光眼市场分为医院、专科诊所、门诊手术中心和其他。2021 年，医院部门预计将在原发性闭角型青光眼市场中占据主导地位，该部门专门开展各种外科手术，并拥有大量专业人员可提供适当的治疗。此外，在安全的医疗环境中提供具有成本效益和高质量的诊断护理和服务，方便咨询医生/医疗机构将批量诊断测试外包给独立的诊断实验室，以提供更好的客户服务。
  • 根据分销渠道，原发性闭角型青光眼市场分为直接招标、零售和其他。2021 年，直接招标部分预计将主导原发性闭角型青光眼市场，因为它们是医疗机构和专科诊所采购诊断和手术设备的主要来源。随着医疗成本的增加，医疗服务提供商正专注于为客户提供更好的服务，同时降低总体成本。通过直接招标采购产品对医疗保健提供商来说具有很高的成本效益。

北美原发性闭角型青光眼市场发展情况

北美原发性闭角型青光眼市场国家级分析

对北美原发性闭角型青光眼市场进行了分析，并提供了市场规模信息，包括产品、疾病类型、类型、最终用户和分销渠道。

北美原发性闭角型青光眼市场报告涵盖的国家包括美国、加拿大和墨西哥。

  • 2021 年，美国预计将占据市场主导地位，因为美国拥有最大的消费市场和高 GDP。此外，美国拥有世界上最大的研发支出，并与多个国家签订了贸易协定，使其成为消费者原发性闭角型青光眼诊断和手术产品的最大市场。由于加拿大经济负担加重，预计该国将在北美市场实现大幅增长。另一方面，由于墨西哥老年人口不断增加，预计在 2021 年至 2028 年的预测期内墨西哥将实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。  

该地区老年人口的增加和闭角型青光眼患病率的上升为北美原发性闭角型青光眼市场参与者创造了新的机会

北美原发性闭角型青光眼市场还为您提供每个国家/地区特定行业增长的详细市场分析，包括原发性闭角型青光眼市场销售、原发性闭角型青光眼市场发展的影响以及监管环境的变化及其对原发性闭角型青光眼市场的支持。数据涵盖 2010 年至 2019 年的历史时期。

竞争格局和北美原发性闭角型青光眼市场份额分析

北美原发性闭角型青光眼市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位和技术生命线曲线。以上提供的数据点仅与公司对原发性闭角型青光眼市场的关注有关。

报告涉及的主要公司包括强生视力保健公司（强生服务公司旗下的子公司）、新世界医疗公司、Sight Sciences 公司、NIDEK 有限公司、BVI、MicroSurgical Technology、艾尔建公司（艾伯维公司旗下的子公司）、博士伦公司（博士伦医疗公司旗下的子公司）、Oertli Instrumente AG、NOVAEYE MEDICAL、蔡司国际、爱尔康公司、LIGHTMED、Luneau Technology USA、Reichert 公司（Ametek 公司旗下的业务部门）以及 NEW VISION 等。

两家公司还在全球范围内推出了多款产品并达成了多项协议，这也加速了原发性闭角型青光眼市场的发展。

例如，

  • 2019 年 10 月，MicroSurgical Technology 宣布已从 Neomedix Corporation 收购 Trabectome 和 Goniotome 手术系统。Trabectome 是青光眼的主要手术技术。此次收购增加了公司的产品组合，从而提高了公司的利润
  • 2018 年 10 月，Reichert, Inc. 宣布推出其新款 Tono-Pen AVIA 手持式眼压计，该眼压计现配备 Quick-Tap 测量模式。Quick-Tap 非常适合对压平眼压计敏感的患者或术后患者。由于患者需求的增加，这款仪器使用起来非常简单

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end user coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. Regulatory Framework
  6. Pipeline analysis
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA
      2. INCREASING WOMEN POPULATION
      3. RISE IN GERIATRIC POPULATION
      4. ADVANCEMENTS IN SURGICAL TREATMENT OF THE DISEASE
      5. INCREASED ECONOMIC BURDEN
    2. RESTRAINTS
      1. HIGH SURGICAL COSTS OF PACG
      2. INADEQUATE REIMBURSEMENT SCENARIO
      3. DELAYED AND MISDIAGNOSIS OF PACG
    3. OPPORTUNITIES
      1. INCREASING GOVERNMENT INITIATIVES TOWARDS GLAUCOMA
      2. RECENT APPROVAL BY GOVERNING BODIES
      3. RAPID TRANSITION FROM PACG MEDICATION TO SURGERIES
    4. CHALLENGES
      1. RISKS ASSOCIATED WITH SURGICAL PROCEDURES
      2. LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
      3. LIMITED ACCESS TO TREATMENT
  8. IMPACT OF COVID-19 ON North america PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS
    5. CONCLUSION
  9. NORTH AMERICA PRIMARY ANGLE CLOSURE GLAUCOMA Market, By DISEASE TYPE
    1. overview
    2. acute angle-closure glaucoma market
    3. chronic angle-closure glaucoma market
  10. North america primary angle-closure glaucoma MARKET, BY TYPE
    1. overview
    2. Diagnosis
      1. primary test
        1. GONIOSCOPY EXAMINATION
        2. SLIT-LAMP EXAMINATION
        3. AUTOMATIC STATIC PERIMETRY
      2. SECONDARY test
        1. ULTRASOUND BIOMICROSCOPY
        2. ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY (OCT)
        3. RETINAL OCT
        4. FUNDOSCOPY
        5. OTHERS
    3. Treatment
      1. Surgical Iridectomy
      2. TRABECULECTOMY
      3. Micro invasive glaucoma technique (MIGS)
      4. goniotomy
      5. Others
  11. North America primary angle-closure glaucoma MARKET, BY end user
    1. overview
    2. HoSpitals
    3. AMbulatory surgical Centers
    4. Specialty Clinics
    5. others
  12. North America Primary Angle-Closure Glaucoma MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retail sales
    4. Others
  13. North America primary angle-closure glaucoma MARKET, BY Country
    1. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
  14. North America primary angle-closure glaucoma Market: COMPANY landscape
    1. company share analysis: North America
  15. SWOT
  16. company profiles
    1. johnson & johnson vision care, inc. (a subsidiary of johnson & johnson services, inc.)
      1. COMPANY SNAPSHot
      2. Revenue analysis
      3. product Portfolio
      4. RECENT DEVELOPMENTS
    2. bausch & lomb incorporated (a subsidiary of bausch health Companies Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. alcon inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. Zeiss International
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. NOVA EYE MEDICAL LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. NIDEK CO., LTD
      1. COMPANY SNAPShot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    7. allergan (a subsidiary of abbvie inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    8. BVI
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    9. LIGHTMED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Luneau technology usa
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. microsurgical technology
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
    12. new vision
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    13. New World Medical, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. Oertli Instrumente AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. Reichert, inc. (A business unit of ametek.inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Sight Sciences, inc.
      1. COMPANY SNAPSHot
      2. product Portfolio
      3. RECENT DEVELOPMENTS
  17. questionnaire
  18. related reports

表格列表

TABLE 1 NORTH AMERICA Primary Angle-Closure Glaucoma Market, Pipeline Analysis

TABLE 2 NUMBER OF OPHTHALMOLOGISTS/MILLION POPULATIONS

TABLE 3 North america Primary angle closure glaucoma market, By disease type, 2019-2028 (USD million)

TABLE 4 North america Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 5 North America Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 6 North america Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 7 North america Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 8 North America Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 9 North America Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 10 North America Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 11 North America PRIMARY ANGLE-CLOSURE GLAUCOMA Market, By country, 2019-2028 (USD Million)

TABLE 12 U.S. PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 13 U.S. Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 14 U.S. Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 15 U.S. Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 16 U.S. Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 17 U.S. Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 18 U.S. Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 19 U.S. Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 20 CANADA PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 21 CANADA Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 22 CANADA Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 23 CANADA Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 24 CANADA Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 25 CANADA Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 26 CANADA Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 27 CANADA Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 28 MEXICO PRIMARY ANGLE-CLOSURE GLAUCOMA Market , By disease Type, 2019-2028 (USD Million)

TABLE 29 MEXICO Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 30 MEXICO Diagnosis in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 31 MEXICO Primary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 32 MEXICO Secondary Test in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 33 MEXICO Treatment in Primary Angle-Closure Glaucoma Market, By Type 2019-2028 (USD Million)

TABLE 34 MEXICO Primary Angle-Closure Glaucoma Market, By End User, 2019-2028 (USD Million)

TABLE 35 MEXICO Primary Angle-Closure Glaucoma Market, By Distribution Channel, 2019-2028 (USD Million)

图片列表

FIGURE 1 NORTH America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: segmentation

FIGURE 2 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET : data triangulation

FIGURE 3 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: North America VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: MULTIVARIATE MODELLING

FIGURE 7 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 North America primary angle-closure glaucoma market: MARKET end user coverage GRID

FIGURE 10 NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 North america primary angle-closure glaucoma market: SEGMENTATION

FIGURE 12 INCREASING PREVALENCE OF ANGLE-CLOSURE GLAUCOMA and ADVANCEMENT IN SURGICAL TREATMENT OF THE DISEASE are DRIVing THE NORTH AMERICA primary angle-closure glaucoma market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 ACUTE ANGLE-CLOSURE GLAUCOMA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET

FIGURE 15 North America Primary angle closure glaucoma market: By disease type, 2020

FIGURE 16 North america Primary angle closure glaucoma market: By disease type, 2020-2028 (USD Million)

FIGURE 17 North America Primary angle closure glaucoma market: By disease type, CAGR (2020-2028)

FIGURE 18 North america Primary angle closure glaucoma market: By disease type, LIFELINE CURVE

FIGURE 19 North america primary angle-closure glaucoma market: BY TYPE, 2020

FIGURE 20 North america primary angle-closure glaucoma market: BY TYPE 2020-2028 (USD Million)

FIGURE 21 North america primary angle-closure glaucoma market: BY TYPE, CAGR (2021-2028)

FIGURE 22 North america primary angle-closure glaucoma market: BY TYPE, LIFELINE CURVE

FIGURE 23 North America Primary Angle-Closure Glaucoma market: BY end user, 2020

FIGURE 24 North America Primary Angle-Closure Glaucoma market: BY end user, 2020-2028 (USD Million)

FIGURE 25 North America Primary Angle-Closure Glaucoma market: BY end user, CAGR (2021-2028)

FIGURE 26 North America Primary Angle-Closure Glaucoma market: BY end user, LIFELINE CURVE

FIGURE 27 North America Primary Angle-Closure Glaucoma market: BY distribution channel, 2020

FIGURE 28 North America Primary Angle-Closure Glaucoma market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 29 North America Primary Angle-Closure Glaucoma market: BY distribution channel, CAGR (2021-2028)

FIGURE 30 North America Primary Angle-Closure Glaucoma market: BY distribution, LIFELINE CURVE

FIGURE 31 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: SNAPSHOT (2020)

FIGURE 32 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020)

FIGURE 33 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2021 & 2028)

FIGURE 34 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY COUNTRY (2020 & 2028)

FIGURE 35 North America PRIMARY ANGLE-CLOSURE GLAUCOMA MARKET: BY type (2021-2028)

FIGURE 36 north america primary angle-closure glaucoma market: company share 2020 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America Primary Angle-Closure Glaucoma Market size will be worth USD 176.34 million by 2028.
The North America Primary Angle-Closure Glaucoma Market growth rate will be 5.7% by 2028.
The Rising prevalence of angle-closure glaucoma and the rise in the geriatric population are the growth drivers of the North America Primary Angle-Closure Glaucoma Market.
The disease type, type, end user, and distribution channel are the factors on which the North America Primary Angle-Closure Glaucoma Market research is based.
The major companies in the North America Primary Angle-Closure Glaucoma Market are Johnson & Johnson Vision Care, Inc. (A Subsidiary of Johnson & Johnson Services Inc.), New World Medical, Inc., Sight Sciences, Inc., NIDEK CO., LTD, BVI, MicroSurgical Technology, Allergan (A Subsidiary of AbbVie Inc.), Bausch & Lomb Incorporated (A Subsidiary of Bausch Health Companies Inc.), Oertli Instrumente AG, NOVAEYE MEDICAL, ZEISS International, Alcon Inc., LIGHTMED, Luneau Technology USA, Reichert, Inc. (A Business Unit of Ametek Inc.).

浏览相关页面

Banner